KRSNAA DIAGNOSTICS LIMITED Financials Krsnaa Diagnostics Limited Bombay S.E.
Equities
KRSNAA
INE08LI01020
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 599.6 INR | 0.00% |
|
+2.42% | -14.99% |
| May. 20 | Krsnaa Diagnostics Names CEO | MT |
| May. 18 | Krsnaa Diagnostics Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 15,344 | 14,449 | 19,348 | - | - |
| Enterprise Value (EV) 1 | 15,344 | 14,449 | 19,845 | 19,348 | 19,348 |
| P/E ratio | 21.4 x | 23.3 x | 34.3 x | 19.6 x | 12.4 x |
| Yield | - | - | 0.33% | 0.5% | 0.83% |
| Capitalization / Revenue | 3.37 x | 2.97 x | 3.2 x | 2.38 x | 1.73 x |
| EV / Revenue | 3.37 x | 2.97 x | 3.2 x | 2.38 x | 1.73 x |
| EV / EBITDA | 11.7 x | 11.8 x | 13.8 x | 9.34 x | 6.65 x |
| EV / FCF | -404 x | -22.2 x | -39.8 x | 90 x | 32.1 x |
| FCF Yield | -0.25% | -4.5% | -2.51% | 1.11% | 3.11% |
| Price to Book | 2.13 x | 1.96 x | 2.38 x | 2.14 x | 1.84 x |
| Nbr of stocks (in thousands) | 31,398 | 31,398 | 32,290 | - | - |
| Reference price 2 | 488.7 | 460.2 | 599.2 | 599.2 | 599.2 |
| Announcement Date | 5/28/22 | 5/27/23 | 5/18/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 4,554 | 4,871 | 6,196 | 8,145 | 11,167 |
| EBITDA 1 | - | 1,315 | 1,223 | 1,442 | 2,070 | 2,908 |
| EBIT 1 | - | 900.9 | 685.2 | 697 | 1,204 | 1,910 |
| Operating Margin | - | 19.78% | 14.07% | 11.25% | 14.79% | 17.11% |
| Earnings before Tax (EBT) 1 | - | 865.1 | 802 | 700.1 | 1,244 | 1,978 |
| Net income 1 | 1,849 | 683.9 | 621.1 | 568.4 | 956.5 | 1,516 |
| Net margin | - | 15.02% | 12.75% | 9.17% | 11.74% | 13.58% |
| EPS 2 | - | 22.88 | 19.78 | 17.90 | 30.50 | 48.30 |
| Free Cash Flow 1 | - | -37.95 | -650.6 | -486 | 215 | 602 |
| FCF margin | - | -0.83% | -13.36% | -7.96% | 2.64% | 5.39% |
| FCF Conversion (EBITDA) | - | - | - | - | 10.38% | 20.7% |
| FCF Conversion (Net income) | - | - | - | - | 22.48% | 39.7% |
| Dividend per Share 2 | - | - | - | 2.000 | 3.000 | 5.000 |
| Announcement Date | 8/3/21 | 5/28/22 | 5/27/23 | 5/18/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,226 | 1,332 | 1,396 | 1,608 | 1,550 | 1,650 |
| EBITDA 1 | - | 294.1 | 344.8 | 313.6 | 403 | 348 | 403 |
| EBIT | - | - | - | - | - | 186 | 226 |
| Operating Margin | - | - | - | - | - | 12% | 13.7% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Net income 1 | 153.4 | 136.4 | 189.2 | 146.4 | 203.5 | 146 | 153.5 |
| Net margin | - | 11.12% | 14.2% | 10.49% | 12.66% | 9.42% | 9.31% |
| EPS | - | - | - | - | 7.400 | 5.350 | 5.000 |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 11/9/22 | 2/13/23 | 5/27/23 | 8/12/23 | - | - | - |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -38 | -651 | -486 | 215 | 602 |
| ROE (net income / shareholders' equity) | - | 14.9% | 8.73% | 7.25% | 11.9% | 14% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 229.0 | 235.0 | 251.0 | 280.0 | 326.0 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 1,322 | 1,414 | 1,675 | 1,750 | 1,500 |
| Capex / Sales | - | 29.03% | 29.02% | 27.45% | 21.49% | 13.43% |
| Announcement Date | 8/3/21 | 5/28/22 | 5/27/23 | 5/18/24 | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
599.2
INR
Average target price
952
INR
Spread / Average Target
+58.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -17.05% | 8.55B | |
| +68.22% | 4.24B | |
| -1.63% | 2.53B | |
| -9.63% | 2.44B | |
| -38.23% | 2.35B | |
| -7.85% | 1.89B | |
| -17.74% | 1.55B | |
| -39.48% | 1.23B | |
| +9.68% | 1.13B |
- Stock Market
- Equities
- KRSNAA Stock
- KRSNAA Stock
- Financials Krsnaa Diagnostics Limited
